Evidence map›Paper›PMID 33669021›Full record

ArticleInternational journal of molecular sciences2021

P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.

Sara da Mata, Joana Ferreira, Inmaculada Nicolás, Susana Esteves, Gonçalo Esteves, Sofia Lérias, Fernanda Silva, Adela Saco, Daniela Cochicho, Mário Cunha and 3 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. A Direct Comparative Analysis of HPV DNA with Single-Molecule RNA and p16JID innovations : skin science from molecules to population health · 2025
    Article
  12. Article
  13. Expanding the Horizons of ctHPVDNA Testing.Head and neck pathology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Sara da MataDepartment of Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil, 1099-023 Lisbon, Portugal.
Joana FerreiraDepartment of Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil, 1099-023 Lisbon, Portugal.ORCID 0000-0002-3752-0013
Inmaculada NicolásInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-9600-8434
Susana EstevesClinical Investigation Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, 1099-023 Lisbon, Portugal.ORCID 0000-0001-8779-8665
Gonçalo EstevesDepartment of Pathology, Centro Hospitalar e Universitário de Lisboa Central, 1150-199 Lisboa, Portugal.
Sofia LériasDepartment of Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil, 1099-023 Lisbon, Portugal.
Fernanda SilvaNova Medical School, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal.ORCID 0000-0002-7652-6493
Adela SacoDepartment of Pathology, Hospital Clínic, University of Barcelona, 08036 Barcelona, Spain.
Daniela CochichoDepartment of Virology, Instituto Português de Oncologia de Lisboa Francisco Gentil, 1099-023 Lisbon, Portugal.
Mário CunhaDepartment of Virology, Instituto Português de Oncologia de Lisboa Francisco Gentil, 1099-023 Lisbon, Portugal.ORCID 0000-0002-9910-9035
Marta Del PinoInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-2178-2403
Jaume OrdiDepartment of Pathology, Hospital Clínic, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-4820-7954
Ana FélixDepartment of Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil, 1099-023 Lisbon, Portugal.ORCID 0000-0002-2653-2262
Universidade Nova de Lisboa · PTConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESBarcelona Institute for Global Health · ESUnidade Local de Saúde de São José · PTUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression of p16 is a good surrogate of human papillomavirus (HPV) infection in HPV-associated cancers. The significance of p16 expression, HPV genotype and genera in the outcome of patients with HPV-associated cervical cancer (CC) is unclear. Our aim is to ascertain the prognostic significance of these factors. Data from 348 patients (median age: 47.5 years old) with CC, diagnosed in two referral centers, were retrospectively collected. Advanced disease (FIGO2018 IB2-IV) was present in 68% of patients. A single HPV genotype was identified in 82.8% of patients. The most common HPVs were HPV16 (69%) and HPV18 (14%). HPV genera reflected this distribution. HPV16 tumors presented at an earlier stage. P16 was negative in 18 cases (5.2%), 83.3% of which were squamous cell carcinomas. These cases occurred in older patients who tended to have advanced disease. In the univariate analysis, HPV16 (HR: 0.58;

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, Squamous CellCohort StudiesCyclin-Dependent Kinase Inhibitor p16FemaleHuman papillomavirus 16Human papillomavirus 18HumansImmunohistochemistryMiddle AgedMultivariate AnalysisPapillomaviridaeBiomarkers, TumorCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16cervical cancerHPVp16 expression

Identifiers

PMID33669021
PMCPMC7956391
OpenAlexW3130056324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.